Matches in SemOpenAlex for { <https://semopenalex.org/work/W3161878006> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W3161878006 abstract "Vaccination is the most competent armament against the barrage of microorganisms. The whole organism vaccines are sporadically inimical to the host because of its secondary constituents such as endotoxins which may induce toxic shock symptoms. Modern Vaccines are bacterial polysaccharides or viral surface proteins which are capable of inducing an immune response in isolation from the attenuated pathogen itself, but the major downside to these relatively modern vaccines is their intrinsic inability to furnish the expected immune response by themselves. Stimulation of the innate immune system by agonists holds the key to the success of recombinant subunit vaccines. The toll-like receptors are pattern recognizing receptors (PRRs) which play an important role in our immunity, and their timely activation by using their corresponding agonists can promote a vigorous immune response to otherwise less immunogenic modern subunit vaccines. TLRs can be rendered active without the presence of the pathogen, provided the specific ligands of the pathogen associated with inducing the immune response is introduced to these receptors. These specific ligands are called agonists, and their utility in the world of vaccination is profound. TLR2 has a special place among the 10 members of the human TLR family because this receptor is capable of detecting the largest repertoire of Pathogen associated molecular patterns (PAMPs) from a large variety of pathogens, including gram-positive or gram-negative bacteria, mycobacteria, fungi, viruses, and parasites. Bacterial lipoproteins are considered the most potent naturally occurring agonists recognized by TLR2. It is the need of the hour to take a proactive approach to develop more immunomodulatory molecules for clinical trials. We are striving towards devising simple and straightforward methods for the synthesis of TLR2 agonistic lipopeptides." @default.
- W3161878006 created "2021-05-24" @default.
- W3161878006 creator A5026256156 @default.
- W3161878006 creator A5040074339 @default.
- W3161878006 creator A5068247384 @default.
- W3161878006 date "2020-02-12" @default.
- W3161878006 modified "2023-09-23" @default.
- W3161878006 title "Straightforward and Productive Methods for Synthesis of Efficacious Tlr2 Agonistic Lipopeptides" @default.
- W3161878006 hasPublicationYear "2020" @default.
- W3161878006 type Work @default.
- W3161878006 sameAs 3161878006 @default.
- W3161878006 citedByCount "0" @default.
- W3161878006 crossrefType "posted-content" @default.
- W3161878006 hasAuthorship W3161878006A5026256156 @default.
- W3161878006 hasAuthorship W3161878006A5040074339 @default.
- W3161878006 hasAuthorship W3161878006A5068247384 @default.
- W3161878006 hasConcept C111289621 @default.
- W3161878006 hasConcept C136449434 @default.
- W3161878006 hasConcept C159047783 @default.
- W3161878006 hasConcept C170493617 @default.
- W3161878006 hasConcept C193419808 @default.
- W3161878006 hasConcept C203014093 @default.
- W3161878006 hasConcept C22070199 @default.
- W3161878006 hasConcept C2776460866 @default.
- W3161878006 hasConcept C2776709828 @default.
- W3161878006 hasConcept C2779341262 @default.
- W3161878006 hasConcept C2779836521 @default.
- W3161878006 hasConcept C2781236682 @default.
- W3161878006 hasConcept C54355233 @default.
- W3161878006 hasConcept C86803240 @default.
- W3161878006 hasConcept C8891405 @default.
- W3161878006 hasConcept C89423630 @default.
- W3161878006 hasConceptScore W3161878006C111289621 @default.
- W3161878006 hasConceptScore W3161878006C136449434 @default.
- W3161878006 hasConceptScore W3161878006C159047783 @default.
- W3161878006 hasConceptScore W3161878006C170493617 @default.
- W3161878006 hasConceptScore W3161878006C193419808 @default.
- W3161878006 hasConceptScore W3161878006C203014093 @default.
- W3161878006 hasConceptScore W3161878006C22070199 @default.
- W3161878006 hasConceptScore W3161878006C2776460866 @default.
- W3161878006 hasConceptScore W3161878006C2776709828 @default.
- W3161878006 hasConceptScore W3161878006C2779341262 @default.
- W3161878006 hasConceptScore W3161878006C2779836521 @default.
- W3161878006 hasConceptScore W3161878006C2781236682 @default.
- W3161878006 hasConceptScore W3161878006C54355233 @default.
- W3161878006 hasConceptScore W3161878006C86803240 @default.
- W3161878006 hasConceptScore W3161878006C8891405 @default.
- W3161878006 hasConceptScore W3161878006C89423630 @default.
- W3161878006 hasLocation W31618780061 @default.
- W3161878006 hasOpenAccess W3161878006 @default.
- W3161878006 hasPrimaryLocation W31618780061 @default.
- W3161878006 hasRelatedWork W1974924706 @default.
- W3161878006 hasRelatedWork W1975593226 @default.
- W3161878006 hasRelatedWork W2016886739 @default.
- W3161878006 hasRelatedWork W2033897405 @default.
- W3161878006 hasRelatedWork W2127475857 @default.
- W3161878006 hasRelatedWork W2143497981 @default.
- W3161878006 hasRelatedWork W2314576162 @default.
- W3161878006 hasRelatedWork W2316550831 @default.
- W3161878006 hasRelatedWork W2324824692 @default.
- W3161878006 hasRelatedWork W2362440784 @default.
- W3161878006 hasRelatedWork W2395719013 @default.
- W3161878006 hasRelatedWork W2397752265 @default.
- W3161878006 hasRelatedWork W2734898349 @default.
- W3161878006 hasRelatedWork W2902663841 @default.
- W3161878006 hasRelatedWork W3025382912 @default.
- W3161878006 hasRelatedWork W3093800261 @default.
- W3161878006 hasRelatedWork W3202049465 @default.
- W3161878006 hasRelatedWork W324633592 @default.
- W3161878006 hasRelatedWork W72027616 @default.
- W3161878006 hasRelatedWork W83136130 @default.
- W3161878006 isParatext "false" @default.
- W3161878006 isRetracted "false" @default.
- W3161878006 magId "3161878006" @default.
- W3161878006 workType "article" @default.